DHER34:BVMF
Danaher Corporation Bdr
R$40.72
0.00%
(0.00) 1D
Oct 20, 4:56:00 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DHER34...
Open
R$40.24
High
R$40.72
Low
R$40.09
Mkt. cap
157.64B
Avg. vol.
2.59K
Volume
69.00
52-wk high
R$45.87
52-wk low
R$27.94
Shares outstanding
702.99M
No. of employees
59K
Open
R$40.24
High
R$40.72
Low
R$40.09
Mkt. cap
157.64B
Avg. vol.
2.59K
Volume
69.00
52-wk high
R$45.87
52-wk low
R$27.94
Shares outstanding
702.99M
No. of employees
59K
News stories
From web sources and news partners
Investing.com South Africa
·
12 hours ago
Danaher earnings on deck as new CEO faces bioprocessing test By Investing.com
Yahoo Finance
·
18 hours ago
Danaher (DHR) Reports Q3: Everything You Need To Know Ahead Of Earnings
Stock Traders Daily
·
1 day ago
(DHR) as a Liquidity Pulse for Institutional Tactics
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corporation Bdr